LONI BANKS: Open Payments
NPI 1508056953 · ELDORADO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 28 payments from 11 companies in 2025. Trend: 2023 $202 · 2024 $429 · 2025 $691
Food & beverage: $591Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $210 |
| Novartis Pharmaceuticals Corporation | 4 | $100 |
| Merck Sharp & Dohme LLC | 5 | $97 |
| ABBVIE INC. | 3 | $81 |
| Daiichi Sankyo Inc. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| PFIZER INC. | 2 | $33 |
| JAZZ PHARMACEUTICALS INC. | 1 | $30 |
| TAIHO ONCOLOGY, INC. | 1 | $20 |
| GENZYME CORPORATION | 1 | $19 |
Products named: RYBREVANT, KEYTRUDA, KISQALI, VENCLEXTA, TECVAYLI, Enhertu, FRUZAQLA, Fabhalta.
Industry payments across IL — which companies pay providers there.
